Progress in Immunosuppressive Agents for Solid-Organ Transplantation

被引:5
|
作者
Zhang, Wynne Qing [1 ]
Vierling, John M. [2 ,3 ,4 ,5 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Div Abdominal Transplantat, Dept Med, Houston, TX 77030 USA
[3] Baylor Coll Med, Div Abdominal Transplantat, Dept Surg, Houston, TX 77030 USA
[4] Baylor Coll Med, Sect Gastroenterol & Hepatol, Dept Med, Houston, TX 77030 USA
[5] Baylor Coll Med, Sect Gastroenterol & Hepatol, Dept Surg, Houston, TX 77030 USA
来源
TEXAS HEART INSTITUTE JOURNAL | 2019年 / 46卷 / 01期
关键词
Drug design; graft rejection/immunology/prevention & control; immunosuppressive agents/therapeutic use; immunosuppression/adverse effects; immunotherapy/methods; Janus kinases/antagonists & inhibitors/immunology; organ transplantation; STAT transcription factors/immunology; signal transduction; INHIBITORS; BLOCKADE;
D O I
10.14503/THIJ-18-6746
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:69 / 70
页数:2
相关论文
共 50 条
  • [1] SOLID-ORGAN TRANSPLANTATION
    LOTT, JA
    ANALYTICAL CHEMISTRY, 1995, 67 (12) : R417 - R424
  • [2] Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation
    Ciuffreda, Donatella
    Pantaleo, Giuseppe
    Pascual, Manuel
    TRANSPLANT INTERNATIONAL, 2007, 20 (08) : 649 - 658
  • [3] Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation
    Alberto Baroja-Mazo
    Beatriz Revilla-Nuin
    Pablo Ramírez
    José A Pons
    World Journal of Transplantation, 2016, (01) : 183 - 192
  • [4] Update on immunosuppressive drugs used in solid-organ transplantation and their nutrition implications
    McPartland, Kenneth J.
    Pomposelli, James J.
    NUTRITION IN CLINICAL PRACTICE, 2007, 22 (05) : 467 - 473
  • [5] CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation
    Wang, Jian
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (04) : 383 - 390
  • [6] Nonadherence to immunosuppressive therapy is a significant problem after solid-organ transplantation
    Kawaguchi S.
    Maniruzzaman M.
    Katsuragi K.
    Matsumoto H.
    Iriany I.
    Ito K.
    Hugenberg N.
    Schmidt M.
    Drugs & Therapy Perspectives, 2002, 18 (12) : 19 - 21
  • [7] Thymoma and solid-organ transplantation
    Guibert, Nicolas
    Brouchet, Laurent
    Rouquette, Isabelle
    Didier, Alain
    Rostaing, Lionel
    Kamar, Nassim
    Mazieres, Julien
    LUNG CANCER, 2012, 77 (01) : 232 - 234
  • [8] INFECTIONS IN SOLID-ORGAN TRANSPLANTATION
    SWENY, P
    BURROUGHS, AK
    CURRENT OPINION IN INFECTIOUS DISEASES, 1994, 7 (04) : 436 - 443
  • [9] Biomarkers in Solid-Organ Transplantation
    Gieser, G.
    Harigaya, H.
    Colangelo, P. M.
    Burckart, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (02) : 217 - 220
  • [10] IMMUNOSUPPRESSION FOR SOLID-ORGAN TRANSPLANTATION
    SHAEFER, MS
    COLLIER, DS
    DIALYSIS & TRANSPLANTATION, 1993, 22 (09) : 542 - &